{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:20:36Z","timestamp":1790637636359,"version":"4.1.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["2000732"],"award-info":[{"award-number":["2000732"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1136418"],"award-info":[{"award-number":["1136418"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1065854"],"award-info":[{"award-number":["1065854"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1183854"],"award-info":[{"award-number":["1183854"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1146128"],"award-info":[{"award-number":["1146128"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["116071"],"award-info":[{"award-number":["116071"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1159261"],"award-info":[{"award-number":["1159261"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pregnancy Hypertension"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.preghy.2021.11.006","type":"journal-article","created":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T12:12:08Z","timestamp":1637151128000},"page":"23-26","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Circulating Activin A is elevated at 36\u00a0weeks\u2019 gestation preceding a diagnosis of preeclampsia"],"prefix":"10.1016","volume":"27","author":[{"given":"Georgia P.","family":"Wong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faith","family":"Andres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan P.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa M.","family":"MacDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Cannon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuong-Vi","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emerson","family":"Keenan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie J.","family":"Hannan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tu'uhevaha J.","family":"Kaitu'u-Lino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.preghy.2021.11.006_b0005","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ajog.2017.04.032","article-title":"Short-term costs of preeclampsia to the United States health care system","volume":"217","author":"Stevens","year":"2017","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"10204","key":"10.1016\/j.preghy.2021.11.006_b0010","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/S0140-6736(19)31963-4","article-title":"Planned early delivery or expectant management for late preterm pre-eclampsia (PHOENIX): a randomised controlled trial","volume":"394","author":"Chappell","year":"2019","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.preghy.2021.11.006_b0015","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1080\/14767050410001668275","article-title":"First-trimester maternal serum activin A in pre-eclampsia and fetal growth restriction","volume":"15","author":"Ong","year":"2004","journal-title":"J. Matern. Fetal Neonatal Med."},{"issue":"2","key":"10.1016\/j.preghy.2021.11.006_b0020","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.cyto.2014.11.017","article-title":"Activin signalling and pre-eclampsia: from genetic risk to pre-symptomatic biomarker","volume":"71","author":"Williamson","year":"2015","journal-title":"Cytokine"},{"issue":"7","key":"10.1016\/j.preghy.2021.11.006_b0025","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1093\/humrep\/deq097","article-title":"Activin A regulates trophoblast cell adhesive properties: implications for implantation failure in women with endometriosis-associated infertility","volume":"25","author":"Stoikos","year":"2010","journal-title":"Hum. Reprod."},{"issue":"9061","key":"10.1016\/j.preghy.2021.11.006_b0030","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/S0140-6736(05)62502-0","article-title":"Activin A, inhibin A, and pre-eclampsia","volume":"349","author":"Lindheimer","year":"1997","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.preghy.2021.11.006_b0035","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/uog.6212","article-title":"Maternal serum inhibin-A and activin-A levels in the first trimester of pregnancies developing pre-eclampsia","volume":"32","author":"Spencer","year":"2008","journal-title":"Ultrasound Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.preghy.2021.11.006_b0040","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.preghy.2016.03.001","article-title":"Role of activin A in the pathogenesis of endothelial cell dysfunction in preeclampsia","volume":"6","author":"Hobson","year":"2016","journal-title":"Pregnancy Hypertens.: Int. J. Women's Cardiovasc. Health"},{"key":"10.1016\/j.preghy.2021.11.006_b0045","unstructured":"summary Apbn. Gestational hypertension and preeclampsia. Obstet Gynecol. 2019;133:211-4."},{"key":"10.1016\/j.preghy.2021.11.006_b0050","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.placenta.2021.01.018","article-title":"Circulating Tissue Factor Pathway Inhibitor (TFPI) is increased preceding preeclampsia diagnosis and in established preeclampsia","volume":"105","author":"MacDonald","year":"2021","journal-title":"Placenta"},{"issue":"5","key":"10.1016\/j.preghy.2021.11.006_b0055","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1080\/gye.16.5.365.372","article-title":"Pre-eclampsia with fetal growth restriction: placental and serum activin A and inhibin A levels","volume":"16","author":"Florio","year":"2002","journal-title":"Gynecol. Endocrinol."},{"issue":"7","key":"10.1016\/j.preghy.2021.11.006_b0060","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1093\/humrep\/15.7.1640","article-title":"Serum inhibin A and activin A are elevated prior to the onset of pre-eclampsia","volume":"15","author":"Muttukrishna","year":"2000","journal-title":"Hum. Reprod."},{"issue":"5","key":"10.1016\/j.preghy.2021.11.006_b0065","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/0143-4004(95)90102-7","article-title":"Hypertension in pregnancy: changes in activin A maternal serum concentration","volume":"16","author":"Petraglia","year":"1995","journal-title":"Placenta"},{"issue":"9061","key":"10.1016\/j.preghy.2021.11.006_b0070","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/S0140-6736(96)09264-1","article-title":"Activin A and inhibin A as possible endocrine markers for pre-eclampsia","volume":"349","author":"Muttukrishna","year":"1997","journal-title":"Lancet"},{"issue":"13","key":"10.1016\/j.preghy.2021.11.006_b0075","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1002\/pd.1606","article-title":"Comparison of activin A and cell-free fetal DNA levels in maternal plasma from patients at high risk for preeclampsia","volume":"26","author":"Diesch","year":"2006","journal-title":"Prenat. Diagn."},{"issue":"8","key":"10.1016\/j.preghy.2021.11.006_b0080","doi-asserted-by":"crossref","first-page":"733","DOI":"10.3109\/14767058.2012.755167","article-title":"Maternal serum activin-A at 30\u201333 weeks in the prediction of preeclampsia","volume":"26","author":"Lai","year":"2013","journal-title":"J. Matern. Fetal. Neonatal. Med."},{"issue":"11","key":"10.1016\/j.preghy.2021.11.006_b0085","doi-asserted-by":"crossref","first-page":"E1415","DOI":"10.1210\/jc.2015-2134","article-title":"Activin A Increases Human Trophoblast Invasion by Inducing SNAIL-Mediated MMP2 Up-Regulation Through ALK4","volume":"100","author":"Li","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.preghy.2021.11.006_b0090","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1677\/JOE-06-0061","article-title":"Oxidative stress increases placental and endothelial cell activin A secretion","volume":"192","author":"Mandang","year":"2007","journal-title":"J. Endocrinol."},{"issue":"1","key":"10.1016\/j.preghy.2021.11.006_b0095","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.preghy.2013.09.002","article-title":"The relationship between Activin A and anti-angiogenic factors in the development of pre-eclampsia","volume":"4","author":"Gurusinghe","year":"2014","journal-title":"Pregnancy Hypertens."},{"issue":"1","key":"10.1016\/j.preghy.2021.11.006_b0100","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ajog.2014.07.021","article-title":"Activin and NADPH-oxidase in preeclampsia: insights from in vitro and murine studies","volume":"212","author":"Lim","year":"2015","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2021.11.006_b0105","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1053\/plac.2002.0930","article-title":"the placenta and the maternal systemic inflammatory response\u2013a review","volume":"24","author":"Redman","year":"2003","journal-title":"Placenta"},{"issue":"5","key":"10.1016\/j.preghy.2021.11.006_b0110","doi-asserted-by":"crossref","first-page":"498","DOI":"10.3109\/14767058.2011.591461","article-title":"Late-onset preeclampsia is associated with an imbalance of angiogenic and anti-angiogenic factors in patients with and without placental lesions consistent with maternal underperfusion","volume":"25","author":"Soto","year":"2012","journal-title":"J. Matern. Fetal. Neonatal. Med."},{"issue":"5","key":"10.1016\/j.preghy.2021.11.006_b0115","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/j.1471-0528.2006.00882.x","article-title":"Morphometric placental villous and vascular abnormalities in early- and late-onset pre-eclampsia with and without fetal growth restriction","volume":"113","author":"Egbor","year":"2006","journal-title":"BJOG"},{"issue":"5","key":"10.1016\/j.preghy.2021.11.006_b0120","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/S0002-9378(96)70056-X","article-title":"Heterogeneous causes constituting the single syndrome of preeclampsia: a hypothesis and its implications","volume":"175","author":"Ness","year":"1996","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"Suppl","key":"10.1016\/j.preghy.2021.11.006_b0125","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.placenta.2013.12.008","article-title":"IFPA Senior Award Lecture: making sense of pre-eclampsia - two placental causes of preeclampsia?","volume":"35","author":"Redman","year":"2014","journal-title":"Placenta"}],"container-title":["Pregnancy Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210778921005420?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210778921005420?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T10:25:54Z","timestamp":1778840754000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210778921005420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":25,"alternative-id":["S2210778921005420"],"URL":"https:\/\/doi.org\/10.1016\/j.preghy.2021.11.006","relation":{},"ISSN":["2210-7789"],"issn-type":[{"value":"2210-7789","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circulating Activin A is elevated at 36\u00a0weeks\u2019 gestation preceding a diagnosis of preeclampsia","name":"articletitle","label":"Article Title"},{"value":"Pregnancy Hypertension","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.preghy.2021.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 International Society for the Study of Hypertension in Pregnancy. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}